• atrial fibrillation

    Prominent publications by Harry J G M C Crijns

    KOL Index score: 21028

    OBJECTIVES: This study aimed to determine the diagnostic accuracy of the 3 most commonly used noninvasive myocardial perfusion imaging modalities, single-photon emission computed tomography (SPECT), cardiac magnetic resonance (CMR), and positron emission tomography (PET) perfusion imaging for the diagnosis of obstructive coronary artery disease (CAD). Additionally, the effect of test and study characteristics was explored.

    BACKGROUND: Accurate detection of obstructive CAD is important ...

    Also Ranks for: Perfusion Imaging |  computed tomography |  cardiac magnetic resonance |  cmr pet |  positron emission
    KOL Index score: 19245

    BACKGROUND: Many patients with atrial fibrillation are at high risk for stroke and require antithrombotic therapy. Antiarrhythmic drugs have not previously been shown to reduce the risk of stroke in atrial fibrillation. The effect of dronedarone, a new multichannel-blocking antiarrhythmic drug, on stroke has been evaluated in a randomized, double-blind clinical trial, ATHENA (A placebo-controlled, double-blind, parallel-arm Trial to assess the efficacy of dronedarone 400 mg BID for the ...

    Also Ranks for: Cardiovascular Hospitalization |  dronedarone patients |  stroke atrial fibrillation |  atrial flutter |  antithrombotic therapy
    KOL Index score: 18245

    OBJECTIVES: The purpose of this study was to assess whether management of heart failure (HF) guided by an individualized N-terminal pro-B-type natriuretic peptide (NT-proBNP) target would lead to improved outcome compared with HF management guided by clinical assessment alone.

    BACKGROUND: Natriuretic peptides may be attractive biomarkers to guide management of heart failure (HF) and help select patients in need of more aggressive therapy. The PRIMA (Can PRo-brain-natriuretic peptide ...

    Also Ranks for: Chronic Heart |  peptide guided |  hf management |  primary point |  admission discharge
    KOL Index score: 15725

    OBJECTIVE: The reporting of depressive symptoms following myocardial infarction may be confounded by complaints originating from the myocardial infarction. Therefore, it is difficult to estimate the effects of post-myocardial infarction depression and its treatment on cardiovascular prognosis. The authors' goal was to study the relationship between depressive symptom dimensions following myocardial infarction and both somatic health status and prospective cardiovascular ...

    Also Ranks for: Cardiovascular Prognosis |  myocardial infarction |  somatic health |  symptom dimensions |  cardiac events
    KOL Index score: 15425

    OBJECTIVES: The aim of this study was to examine the effect of cardioversion on left and right atrial volume in patients with chronic atrial fibrillation and to determine the influence of mitral valve disease on atrial size.

    BACKGROUND: Atrial enlargement is a common finding in atrial fibrillation and has been associated with an increased risk for embolic stroke. In addition, atrial enlargement may hamper long-term maintenance of sinus rhythm after cardioversion.

    METHODS: Forty-one ...

    Also Ranks for: Mitral Valve Disease |  atrial size |  sinus rhythm |  6 months |  fibrillation patients
    KOL Index score: 15098

    BACKGROUND: The EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot) provides systematic collection of contemporary data regarding the management and treatment of 3119 subjects with AF from 9 member European Society of Cardiology (ESC) countries. In this analysis, we report the development of symptoms, use of antithrombotic therapy and rate vs. rhythm strategies, as well as determinants of mortality and/or stroke/transient ischaemic attack ...

    Also Ranks for: Year Follow |  fibrillation patients |  pilot registry |  heart failure |  mortality age
    KOL Index score: 14588

    BACKGROUND: The combination of left bundle branch block (LBBB) morphology and QRS duration is currently used to select patients for cardiac resynchronization therapy (CRT). These parameters, however, have limitations. This study evaluates the value of QRS area compared with that of QRS duration and morphology in the association with clinical and echocardiographic outcomes in a large cohort of CRT patients.

    METHODS: A retrospective multicentre study was conducted in 1492 CRT patients. ...

    Also Ranks for: Qrs Area |  cardiac resynchronization |  patients crt |  bundle branch |  echocardiographic response
    KOL Index score: 14453

    BACKGROUND: Vitamin K antagonists, the current standard treatment for prophylaxis against stroke and systemic embolism in patients with atrial fibrillation, require regular monitoring and dose adjustment; an unmonitored, fixed-dose anticoagulant regimen would be preferable. The aim of this randomised, open-label non-inferiority trial was to compare the efficacy and safety of idraparinux with vitamin K antagonists.

    METHODS: Patients with atrial fibrillation at risk for thromboembolism ...

    Also Ranks for: Atrial Fibrillation |  vitamin antagonists |  thromboembolism patients |  systemic embolism |  treatment idraparinux
    KOL Index score: 14282

    OBJECTIVES: We studied the influence of rate control or rhythm control in patients with persistent atrial fibrillation (AF) on quality of life (QoL).

    BACKGROUND: Atrial fibrillation may cause symptoms like fatigue and dyspnea. This can impair QoL. Treatment of AF with either rate or rhythm control may influence QoL.

    METHOD: Quality of life was assessed in patients included in the Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study (rate vs. rhythm ...

    Also Ranks for: Rhythm Control |  life qol |  persistent atrial |  baseline study |  electrical cardioversion
    KOL Index score: 13862

    OBJECTIVES: The purpose of this study was to evaluate left ventricular function and atrial and ventricular diameters in patients with persistent atrial fibrillation (AF) treated with rate or rhythm control.

    BACKGROUND: Restoration of sinus rhythm in patients with persistent AF may improve left ventricular function and reduce atrial dimensions. Adequate rate control in AF may preserve ventricular function.

    METHODS: In 335 patients included in the RAte Control versus Electrical ...

    Also Ranks for: Ventricular Function |  rate control |  persistent atrial fibrillation |  electrical cardioversion |  sinus rhythm patients
    KOL Index score: 13826

    BACKGROUND: Maintenance of sinus rhythm is the main therapeutic goal in patients with atrial fibrillation. However, recurrences of atrial fibrillation and side effects of antiarrhythmic drugs offset the benefits of sinus rhythm. We hypothesized that ventricular rate control is not inferior to the maintenance of sinus rhythm for the treatment of atrial fibrillation.

    METHODS: We randomly assigned 522 patients who had persistent atrial fibrillation after a previous electrical cardioversion ...

    Also Ranks for: Rhythm Control |  atrial fibrillation |  primary point |  patients rate |  death cardiovascular
    KOL Index score: 13685

    BACKGROUND: Despite improvements in the management of atrial fibrillation, patients with this condition remain at increased risk for cardiovascular complications. It is unclear whether early rhythm-control therapy can reduce this risk.

    METHODS: In this international, investigator-initiated, parallel-group, open, blinded-outcome-assessment trial, we randomly assigned patients who had early atrial fibrillation (diagnosed ≤1 year before enrollment) and cardiovascular conditions to receive ...

    Also Ranks for: Early Rhythm |  atrial fibrillation |  control therapy |  patients usual |  ventricular function
    KOL Index score: 13514

    BACKGROUND: Dronedarone is a new antiarrhythmic drug that is being developed for the treatment of patients with atrial fibrillation.

    METHODS: We conducted a multicenter trial to evaluate the use of dronedarone in 4628 patients with atrial fibrillation who had additional risk factors for death. Patients were randomly assigned to receive dronedarone, 400 mg twice a day, or placebo. The primary outcome was the first hospitalization due to cardiovascular events or death. Secondary outcomes ...

    Also Ranks for: Cardiovascular Events |  atrial fibrillation |  death patients |  hazard ratio |  study drug
    KOL Index score: 13232

    AIMS: Guideline-adherent therapy for stroke prevention in atrial fibrillation has been associated with better outcomes, in terms of thromboembolism (TE) and bleeding.

    METHODS AND RESULTS: In this report from the EuroObservational Research Programme-Atrial Fibrillation (EORP-AF) Pilot General Registry, we describe the associated baseline features of 'high risk' AF patients in relation to guideline-adherent antithrombotic treatment, i.e. whether they were adherent, over-treated, or ...

    Also Ranks for: Atrial Fibrillation |  antithrombotic treatment |  oral aged aged |  esc guidelines |  guideline adherent


    Harry J G M C Crijns: Influence Statistics

    Sample of concepts for which Harry J G M C Crijns is among the top experts in the world.
    Concept World rank
    afvtvi atrium #1
    lvlw #1
    control rhythm #1
    dac 95 #1
    n20 multilink #1
    ecg parameters maintenance #1
    lbbb lbbb definition #1
    qol followup #1
    genetic familial dcm #1
    ablationprocedure #1
    extent cardiac involvement #1
    verapamil versus #1
    021258 #1
    aa propagation hypothesis #1
    metaanalysis echocardiographic predictors #1
    eatv catheter ablation #1
    disease electric #1
    mhealth solutions detection #1
    138 pss #1
    invasivetesting #1
    longstanding atrial fibrillation #1
    adverse outcome hfpef #1
    autonomic nervous goats #1
    month cardioversion #1
    goats atrial fibrosis #1
    arrhythmia duration #1
    holter monitoring ack #1
    afl recurrence patients #1
    probnp pai1 #1
    nct01288352 #1
    efficacy cardiovert #1
    patients ventricular enhancement #1
    arrhythmia wpw patients #1
    sinus rhythm maintenance #1
    verapamil aerp #1
    vka asac #1
    qtc t1d #1
    fibrillatory velocity ecv #1
    clinical parameters maintenance #1
    intraatrial conduction delay #1
    cabgn #1
    pwd hp #1
    serial cardioversion therapy #1
    aa propagation #1
    80 beats #1
    nonresponders flecainide #1
    strict rate control #1
    symptomrhythm correlation patients #1
    atrial blood supply #1
    asac avc #1

    Key People For Atrial Fibrillation

    Top KOLs in the world
    Gregory Yoke Hong Lip
    atrial fibrillation heart failure stroke prevention
    John Camm MD John Camm
    atrial fibrillation myocardial infarction heart rate
    Emelia J Benjamin
    atrial fibrillation framingham heart study heart failure
    Harry J G M C Crijns
    atrial fibrillation heart failure sinus rhythm
    Isabelle C Van Gelder
    atrial fibrillation heart failure rate control
    Stefan Hans Hohnloser
    atrial fibrillation myocardial infarction sinus rhythm

    Harry J G M C:Expert Impact

    Concepts for whichHarry J G M Chas direct influence:Atrial fibrillation,  Heart failure,  Sinus rhythm,  Rate control,  Rhythm control,  Patients atrial fibrillation,  Myocardial infarction,  Electrical cardioversion.

    Harry J G M C:KOL impact

    Concepts related to the work of other authors for whichfor which Harry J G M C has influence:Atrial fibrillation,  Heart failure,  Catheter ablation,  Sinus rhythm,  Ischemic stroke,  Myocardial infarction,  Oral anticoagulants.



    Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

    Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, Netherlands | Cardiovascular Research Institute Maastricht (CARIM), Physiology, Maastricht, Netherlands | Em. Professor